Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,779 results

Filters applied: . Clear all
Page 1
Response to Letter to the Editor Regarding "The Mid-term Outcome of Intervertebral Disc Degeneration after Direct Vertebral Rotation in Adolescent Idiopathic Scoliosis: Magnetic Resonance Imaging-based Analysis for a Mean 11.6-year Follow-up".
Kim HJ, Chang DG, Lenke LG, Pizones J, Castelein R, Trobisch PD, Cheung JPY, Suk SI. Kim HJ, et al. Spine (Phila Pa 1976). 2024 May 14. doi: 10.1097/BRS.0000000000005033. Online ahead of print. Spine (Phila Pa 1976). 2024. PMID: 38741513 No abstract available.
MASLD/MetALD and mortality in individuals with any cardio-metabolic risk factor: a population based study with 26.7 years of follow-up.
Kwak M, Kim HS, Jiang ZG, Yeo YH, Trivedi HD, Noureddin M, Yang JD. Kwak M, et al. Among authors: kim hs. Hepatology. 2024 May 13. doi: 10.1097/HEP.0000000000000925. Online ahead of print. Hepatology. 2024. PMID: 38739848
BACKGROUND AIMS: A new term, metabolic dysfunction-associated steatotic liver disease(MASLD), has been proposed by a multi-society expert panel. ...Therefore controlling metabolic risk factors and reducing alcohol consumption in people with MASLD or MetALD will be crucial …
BACKGROUND AIMS: A new term, metabolic dysfunction-associated steatotic liver disease(MASLD), has been proposed by a multi-society ex …
Expanding Clinical Spectrum of Anti-GQ1b Antibody Syndrome: A Review.
Lee SU, Kim HJ, Choi JY, Choi KD, Kim JS. Lee SU, et al. Among authors: kim hj. JAMA Neurol. 2024 May 13. doi: 10.1001/jamaneurol.2024.1123. Online ahead of print. JAMA Neurol. 2024. PMID: 38739407
IMPORTANCE: The discovery of the anti-GQ1b antibody has expanded the nosology of classic Miller Fisher syndrome to include Bickerstaff brainstem encephalitis, Guillain-Barre syndrome with ophthalmoplegia, and acute ophthalmoplegia without ataxia, which have been brought under the …
IMPORTANCE: The discovery of the anti-GQ1b antibody has expanded the nosology of classic Miller Fisher syndrome to include Bickerstaff brain …
Spatio-temporal dynamics of the human small intestinal microbiome and its response to a synbiotic.
An R, Wilms E, Gerritsen J, Kim HK, Pérez CS, Besseling-van der Vaart I, Jonkers DMAE, Rijkers GT, de Vos WM, Masclee AAM, Zoetendal EG, Troost FJ, Smidt H. An R, et al. Among authors: kim hk. Gut Microbes. 2024 Jan-Dec;16(1):2350173. doi: 10.1080/19490976.2024.2350173. Epub 2024 May 13. Gut Microbes. 2024. PMID: 38738780 Clinical Trial.
Increased metabolic activity of probiotic strains during intestinal passage, as assessed by metatranscriptome analysis, was not observed. Nevertheless, synbiotic supplementation led to a short-term spike in the relative abundance of genera included in the product in the sm …
Increased metabolic activity of probiotic strains during intestinal passage, as assessed by metatranscriptome analysis, was not observed. Ne …
GNUV201, a novel human/mouse cross-reactive and low pH-selective anti-PD-1 monoclonal antibody for cancer immunotherapy.
Kim HM, Kim KJ, Lee K, Yoon MJ, Choih J, Hong TJ, Cho EJ, Jung HJ, Kim J, Park JS, Na HY, Heo YS, Park CG, Park H, Han S, Bae D. Kim HM, et al. BMC Immunol. 2024 May 11;25(1):29. doi: 10.1186/s12865-024-00609-z. BMC Immunol. 2024. PMID: 38730320 Free PMC article.
The epitope of GNUV201 mapped to the "FG loop" of hPD-1, distinct from those of Keytruda() ("C'D loop") and Opdivo() (N-term). Notably, the structural feature where the protruding epitope loop fits into GNUV201's binding pocket supports the enhanced binding affinity due to …
The epitope of GNUV201 mapped to the "FG loop" of hPD-1, distinct from those of Keytruda() ("C'D loop") and Opdivo() (N-term). Notabl …
Evaluation of thoracic sympathetic ganglion block as a predictor for response to ketamine infusion therapy and spinal cord stimulation in patients with chronic upper extremity pain.
Kim J, Kim H, Kim JE, Yoo Y, Moon JY. Kim J, et al. Among authors: kim h. Pain Med. 2024 May 9:pnae038. doi: 10.1093/pm/pnae038. Online ahead of print. Pain Med. 2024. PMID: 38724239
Among 32 patients who underwent SCS implantation, 68.8% (n = 22) experienced short-term effectiveness. Positive response to TSGB was significantly higher in SCS responders (45.5%, n = 10) than in non-responders (0.0%). ...
Among 32 patients who underwent SCS implantation, 68.8% (n = 22) experienced short-term effectiveness. Positive response to TSGB was …
Seasonal variation and prognosis in patients with acute myocardial infarction complicated by cardiogenic shock.
Jung S, Jang WJ, Lee WS, Park IH, Oh JH, Yang JH, Gwon HC, Ahn CM, Yu CW, Kim HJ, Bae JW, Kwon SU, Lee HJ, Jeong JO, Park SD. Jung S, et al. Among authors: kim hj. Heliyon. 2024 Apr 24;10(9):e30078. doi: 10.1016/j.heliyon.2024.e30078. eCollection 2024 May 15. Heliyon. 2024. PMID: 38720697 Free PMC article.
CONCLUSIONS: After adjusting for baseline differences, seasonal variation seems not to influence the mid-term risk of 12-month MACE in patients treated with PCI for AMI complicated by CS. ...The study suggests that seasonal variation has no impact on the mid-term ri …
CONCLUSIONS: After adjusting for baseline differences, seasonal variation seems not to influence the mid-term risk of 12-month MACE i …
Validation of MELD 3.0 in patients with alcoholic liver cirrhosis using prospective KACLiF cohort.
Lim J, Kim JH, Kim SE, Han SK, Kim TH, Yim HJ, Jung YK, Song DS, Yoon EL, Kim HY, Kang SH, Chang Y, Yoo JJ, Lee SW, Park JG, Park JW, Jeong SW, Suk KT, Kim MY, Kim SG, Kim W, Jang JY, Yang JM, Kim DJ; Korean Acute on‐Chronic Liver Failure (KACLiF) Study Group. Lim J, et al. Among authors: kim hy. J Gastroenterol Hepatol. 2024 May 8. doi: 10.1111/jgh.16591. Online ahead of print. J Gastroenterol Hepatol. 2024. PMID: 38720448
BACKGROUND AND AIM: The Model for End-Stage Liver Disease (MELD) is a reliable prognostic tool for short-term outcome prediction in patients with end-stage liver disease. ...
BACKGROUND AND AIM: The Model for End-Stage Liver Disease (MELD) is a reliable prognostic tool for short-term outcome prediction in p …
Comparative analysis of recurrence rates between intravesical gemcitabine and bacillus Calmette-Guérin induction therapy following transurethral resection of bladder tumors in patients with intermediate- and high-risk bladder cancer: A retrospective multicenter study.
Choi J, Kim KH, Kim HS, Yoon HS, Kim JH, Kim JW, Lee YS, Choi SY, Chang IH, Ko YH, Song W, Jeong BC, Nam JK. Choi J, et al. Among authors: kim hs. Investig Clin Urol. 2024 May;65(3):248-255. doi: 10.4111/icu.20230313. Investig Clin Urol. 2024. PMID: 38714515 Free PMC article.
CONCLUSIONS: Intravesical gemcitabine demonstrated efficacy comparable to BCG therapy for the first year in patients with intermediate- and high-risk NMIBC. However, long-term follow-up studies are warranted....
CONCLUSIONS: Intravesical gemcitabine demonstrated efficacy comparable to BCG therapy for the first year in patients with intermediate- and …
4,779 results